Chelation Therapy (EDTA)

Some thirty years ago it was found that infusing EDTA into the veins by an intravenous drip caused a remarkable improvement in angina and heart disease, and in poor circulation affecting the legs and the brain as a result of arteriosclerosis.

What Is EDTA Chelation?
EDTA (ethylene-diamine-tetra-acetic acid) is a synthetic amino acid and is given by a 'drip' (also called an infusion) into a vein in the arm. EDTA is called a chelating agent in that it 'grasps' or 'hooks on to' certain minerals and heavy metals.

How Exactly Does it Work?
In arterial disease, the blood vessels are damaged in various ways, and they become blocked by a build-up of calcium-rich fatty tissue called plaque. EDTA works by binding to atoms of calcium, lead, cadmium, mercury, copper, iron, and several other minerals in the body. The EDTA, together with the metals attached to it, then passes out of the body through the kidneys and urine.

As a result, arterial plaque is broken down slowly and circulation throughout the body improves. The process that caused the plaque to accumulate slows down and can reverse, and other dangerous processes that cause instability and spasm of arteries in the heart and elsewhere may also reversed.

Chelation therapy also removes toxic metals from the body and this can greatly reduce a person's toxic load, leading to an increase in energy and vitality. For this reason it can be helpful in many conditions.

How is EDTA Chelation Therapy administered?
EDTA in liquid form is added to various vitamins and minerals as in IVVT and given through an IV line. Each treatment can take up to three hours and typically 20-30 treatments are required.

How Effective Is EDTA Chelation Therapy?
It is consistently very effective. A majority of patients receiving chelation therapy will have improvements in their symptoms, supported by improvement in objective tests such as blood pressure, circulation, and joint play.

In a study in Denmark between 1987 and 1993, 92 patients who had been referred for surgery (coronary artery bypass or foot amputation) received intravenous EDTA chelation therapy.

In 82 of them (89%) the surgeons later cancelled the operations because they were no longer necessary. (The estimated saving to the Danish health service was 1.2 million pounds.)

The patients in this study were treated at two different clinics, but they received identical treatment. In 1999, one of the clinics involved decided to review their patients (52 of the 92) from the original study, and they were able to contact all but 5 of the patients they had chelated.

Of these 47 patients, all of whom had been told more than 10 years earlier that bypass or amputation was inevitable, 34 had still not required surgical intervention and were well. Ten patients had proceeded to surgery and three patients had died.

Why Have I Not Heard About Chelation Before?
EDTA chelation therapy is a common practice in mainstream medicine - and therefore unpublicised - although several million treatments have been given worldwide over forty years with overwhelmingly positive results and without serious adverse effects.

There are several reasons for this:

Most medical research is funded (and driven) by the pharmaceutical and medical equipment industries. No pharmaceutical company has found it worth its while to fund research into EDTA because it could potentially reduce sales of their other drugs and equipment.
There are hundreds of studies such as the one described above, but they are usually rejected by the major mainstream medical journals, and have to be published in more specialized journals that are not widely read. Thus, many doctors are not aware of the research.
The mode of action of EDTA chelation is so different from the normal medical approach, that there is a built-in belief in many doctors that it simply cannot work. For them, no amount of evidence will ever be enough.

Top of Page

acupuncture | chiropractic | massage therapy | naturopathic | orthotics